The latest from BioStock
» CLS launches in France
» Aqilion's new program will be Best-in-Class
» Biosergen CEO “It is a global health threat that requires action”
» Annexin CEO: “The chances of success for ANXV have increased”
» Flerie Invest continues to support Lipum
Read BioStock's weekly newsletter for v.19 here.
News from the last 24 hours
updates its financial target for adjusted EPS growth 2024-2028 taking into account decisions from FDA. Read more.
SUFFER appoints Mats Wiking to a new CEO. Read more.
BioInvent presents phase I/IIa data at European Hematology Association (EHA) Congress 2024 for BI-1206 with rituximab in non-Hodgkin's lymphoma. Read more.
Genmab will present several new results for Epcoritamab at EHA. Read more.
Cereno Scientific will present preclinical data for CS585 at EHA. Read more.
Fluicell expands the capacity of the platform Nexocyte in cardiac tissue screening. Read more.
BioArctics Partner Eisai begins phased application to the FDA for subcutaneous maintenance treatment with leqembi. Read moreEisai expects Leqembi sales to reach JPY 56,5 billion during April 2024-March 2025. Read more.
AlzeCure Pharma announces that Eli Lilly's and AstraZeneca former head of research Dr. Jan Lundberg has been elected as a board member. Read more.
Calliditas Therapeutics Partner Everest Medicines launches Nefecon in China. Read more.
Integral has been granted a registered trademark for OPRA Implant System in the EU. Read more.
Lipigon Pharmaceuticals and Leaderna Therapeutics is making progress in the development of Lipisense. Read more.
Level Cinema has received conditional approval for listing on Nordic Growth Market. Read more.
European Institute of Science presents the outcome of the rights issue. Read more. Flagging announcement in the company. Read more.
Eurocine Vaccines announces that the last day for trading in warrants of series TO 5 is today, May 15. Read moreThe company presents proposed board members. Read more.
Chordate Medical presents Ozilia on Pharma Partnering EU Summit 2024. Read more.
Fluicell announces that today the exercise period for warrants of series TO5 begins. Read more.
Lumito attending the Spring Meeting of Pathology 2024 in Kalmar. Read more.
Reports
BibbInstruments Cessatech EQL Pharma Diagonal Bio Intervacc Implantica lundbeck Photocure SenzaGen
Meetings and communiqués
Acarix AlzeCure Pharma Bactiguard Bio Vitos Pharma ContextVision Devyser Diagnostics Inhalation Sciences Sweden Inify Laboratories Kancera Moberg Pharma Navamedic Lytix Biopharma Perpetua Medical Scandinavian ChemoTech Sobi Ray Intelligence Stenocare Surgical Science
This morning's price development
Index: OMXS30 -0,3% Healthcare -0,46%
| Winner | Förlorare |
| Eurocine Vaccines +18,57% | Diagonal Cinema -48,93% |
| Egetis Therapeutics +16,64% | Cline Scientific -27,08% |
| PharmaLundensis +14,74% | Surgical Science -19,17% |
| Zenicor +10,71% | Sperm count -16,29% |
| Abera Bioscience +9,58% | Ecti Research -12,66% |